BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7913088)

  • 1. Changes of colon epithelium proliferation due to individual aging with cyclin proliferating cell nuclear antigen (PCNA/cyclin) immunostaining compared to [3H]-thymidine radioautography.
    Morita T; Usuda N; Hanai T; Nagata T
    Histochemistry; 1994 Jan; 101(1):13-20. PubMed ID: 7913088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.
    Galand P; Degraef C
    Cell Tissue Kinet; 1989 Sep; 22(5):383-92. PubMed ID: 2575456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity in the kidneys of aging mice evaluated by PCNA/cyclin immunohistochemistry.
    Hanai T; Usuda N; Morita T; Shimizu T; Nagata T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):181-91. PubMed ID: 8099838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
    Bleiberg H; Morret M; Galand P
    Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
    He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
    Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
    Zeymer U; Fishbein MC; Forrester JS; Cercek B
    Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S phase duration measurement by combined PCNA/cyclin immunostaining and radioautography after a single pulse-labelling with 3H-thymidine.
    Morret-Rauis M; Degraef C; Galand P
    Cell Biol Int Rep; 1990 Sep; 14(9):765-74. PubMed ID: 1980636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.
    Foley J; Ton T; Maronpot R; Butterworth B; Goldsworthy TL
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):199-205. PubMed ID: 7912186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCNA/cyclin defined proliferative activity of epithelial cells in normal gastric mucosa and in chronic gastritis.
    Bielicki D; Markiewski M; Marlicz K; Domaga+a W
    Patol Pol; 1993; 44(2):75-8. PubMed ID: 8103592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
    Diebold J; Lai MD; Löhrs U
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine.
    Dietrich DR; Candrian R; Marsman DS; Popp JA; Kaufmann WK; Swenberg JA
    Cancer Lett; 1994 Apr; 79(1):45-51. PubMed ID: 7910515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium.
    Weisgerber UM; Boeing H; Nemitz R; Raedsch R; Waldherr R
    Gut; 1993 Nov; 34(11):1587-92. PubMed ID: 7902310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
    Coltrera MD; Gown AM
    J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of insulin on DNA synthesis in suckling mouse colon.
    Ménard D; Dagenais P
    Biol Neonate; 1993; 63(5):310-5. PubMed ID: 8353160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
    Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F
    Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the effects of aging on macromolecular synthesis in mouse steroid secreting cells using microscopic radioautography.
    Nagata T; Ito M; Liang Y; Gao F
    Methods Find Exp Clin Pharmacol; 2000; 22(1):5-18. PubMed ID: 10791289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of S phase duration in human epidermis using cyclin immunostaining and 3H-thymidine pulse labelling.
    Berlingin E; Heenen M; Galand P
    Arch Dermatol Res; 1992; 284(4):238-41. PubMed ID: 1417071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1992; 12(2):577-83. PubMed ID: 1349799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.